World Of Taxonomy
C191722Level 4

Dose-dense AC Followed by Dose-Dense Paclitaxel/Trastuzumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of doxorubicin and cyclophosphamide, followed by a dose-dense regimen of paclitaxel, and trastuzumab that may be used in the treatment of breast cancer.

**Synonyms:** - DD Doxorubicin/Cyclophosphamide Followed by DD Paclitaxel Plus Trastuzumab - Dose-dense AC Followed by Dose-Dense Paclitaxel Plus Trastuzumab - Dose-dense AC Followed by Dose-Dense Paclitaxel Plus Trastuzumab Regimen - Dose-dense Adriamycin/Cytoxan Followed by Dose-dense Taxol Plus Herceptin - Dose-dense Doxorubicin/Cyclophosphamide Followed by Dose-dense Paclitaxel Plus Trastuzumab - ddAC-ddTH (Paclitaxel) - ddAC-ddTH (Paclitaxel) (trastuzumab-anns) - ddAC-ddTH (Paclitaxel) (trastuzumab-dkst) - ddAC-ddTH (Paclitaxel) (trastuzumab-dttb) - ddAC-ddTH (Paclitaxel) (trastuzumab-herw) - ddAC-ddTH (Paclitaxel) (trastuzumab-pkrb) - ddAC-ddTH (Paclitaxel) (trastuzumab-qyyp) - ddAC-ddTH (Paclitaxel) (trastuzumab-strf) - ddAC-ddTH (Paclitaxel) (trastuzumab-zerc)

GET/api/v1/systems/nci_thesaurus/nodes/C191722
Official DownloadCC BY 4.0Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.